TY - JOUR
T1 - Estimating health care costs related to cancer treatment from SEER-Medicare data.
AU - Brown, Martin L.
AU - Riley, Gerald F.
AU - Schussler, Nicki
AU - Etzioni, Ruth
PY - 2002/8
Y1 - 2002/8
N2 - BACKGROUND: Cancer-specific medical care costs are used by health service researchers, medical decision analysts, and health care policymakers. The SEER-Medicare database is a unique data resource that makes it possible to derive incidence- and prevalence-based estimates of cancer-related medical care costs by site and stage of disease, by treatment approach, and for age and gender strata for individuals older than 65 years. OBJECTIVES: This paper describes the cost-related data available in the SEER-Medicare database, and discusses techniques and methods that have been used to derive various cost estimates from these data. The limitations of SEER-Medicare data as a source of cost estimates are also discussed. RESULTS: Examples of cost estimates for colorectal and breast cancer derived from SEER-Medicare are presented, including estimates of incidence-based cost (average cost per patient) by the initial, terminal, and continuing care phases of cancer treatment. Estimates of cancer-related treatment costs, costs by type of treatment, and long-term costs are presented, as are prevalence-based costs (aggregate Medicare and national expenditures) by cancer type.
AB - BACKGROUND: Cancer-specific medical care costs are used by health service researchers, medical decision analysts, and health care policymakers. The SEER-Medicare database is a unique data resource that makes it possible to derive incidence- and prevalence-based estimates of cancer-related medical care costs by site and stage of disease, by treatment approach, and for age and gender strata for individuals older than 65 years. OBJECTIVES: This paper describes the cost-related data available in the SEER-Medicare database, and discusses techniques and methods that have been used to derive various cost estimates from these data. The limitations of SEER-Medicare data as a source of cost estimates are also discussed. RESULTS: Examples of cost estimates for colorectal and breast cancer derived from SEER-Medicare are presented, including estimates of incidence-based cost (average cost per patient) by the initial, terminal, and continuing care phases of cancer treatment. Estimates of cancer-related treatment costs, costs by type of treatment, and long-term costs are presented, as are prevalence-based costs (aggregate Medicare and national expenditures) by cancer type.
UR - http://www.scopus.com/inward/record.url?scp=0036676214&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036676214&partnerID=8YFLogxK
U2 - 10.1097/00005650-200208001-00014
DO - 10.1097/00005650-200208001-00014
M3 - Article
C2 - 12187175
AN - SCOPUS:0036676214
SN - 0025-7079
VL - 40
SP - IV-104-117
JO - Medical care
JF - Medical care
IS - 8 Suppl
ER -